Holen Sie sich die Stockscreener-App
0.8691
0.10%
-0.0009
Biofrontera Inc Aktie (BFRI) Neueste Nachrichten
Biofrontera (BFRI) to Release Earnings on Thursday - Defense World
Are healthcare shares trailing behind Align Technology (ALGN) in performance this year? - Bitget
PTA-Adhoc: Biofrontera AG: Financial Guidance for FY 2026 - TradingView
Market Rankings: Is Biofrontera Inc backed by strong institutional buying2026 Opening Moves & Verified Swing Trading Watchlists - baoquankhu1.vn
Biofrontera Inc. (BFRI) Upgraded to Buy: Here's Why - Bitget
Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 19, 2026 - The Manila Times
Biofrontera Inc. to Report Fourth Quarter and Full Year - GlobeNewswire
Biofrontera reports Phase 2b acne trial results for Ameluz PDT - Investing.com India
Biofrontera Reports Positive Phase 2b Acne Trial Results - TipRanks
Biofrontera Inc. Reports Positive Phase 2b Results Supporting Further Development of Ameluz® Photodynamic Therapy for moderate to severe Acne Vulgaris - The Manila Times
Biofrontera reports positive Phase 2b Ameluz PDT results for moderate to severe acne - TradingView
Biofrontera Inc. Reports Positive Phase 2b Results - GlobeNewswire
Is Biofrontera Inc. backed by strong institutional buyingQuarterly Portfolio Summary & Safe Entry Trade Reports - baoquankhu1.vn
Loss Report: Does Biofrontera Inc have a sustainable dividendDollar Strength & Step-by-Step Trade Execution Guides - baoquankhu1.vn
BFRIW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Will Biofrontera Inc. stock go up in YEAR2025 Top Gainers & Risk Controlled Stock Alerts - mfd.ru
Bank Watch: Is Biofrontera Inc a play on infrastructure spendingJuly 2025 Final Week & AI Enhanced Execution Alerts - baoquankhu1.vn
Biofrontera wins patent ruling against Sun Pharma in dispute By Investing.com - Investing.com Canada
Biofrontera wins patent ruling against Sun Pharma in dispute - Investing.com
Biofrontera reports USPTO decision on Sun Pharma’s challenged claims - TipRanks
Biofrontera Wins Key PTAB Ruling in Sun Patent Dispute - TipRanks
Biofrontera (NASDAQ: BFRI) wins PTAB decision on Sun Pharma patent claims - Stock Titan
U.S. Patent Office Issues Final Written Decision Finding - GlobeNewswire
Gains Recap: Will Biofrontera Inc stock go up in YEAR2025 Trading Recap & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Is Biofrontera Inc. stock technically oversoldWeekly Stock Analysis & Community Consensus Trade Signals - mfd.ru
Growth Value: Can Biofrontera Inc Equity Warrant sustain its profitabilityLong Setup & Weekly Breakout Watchlists - baoquankhu1.vn
Trading Action: Does Biofrontera Inc have high return on assets2025 Risk Factors & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Can Biofrontera Inc Equity Warrant sustain its profitabilityMarket Growth Report & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
How Biofrontera Inc. Equity Warrant stock responds to policy changesJuly 2025 Retail & Low Drawdown Momentum Ideas - mfd.ru
Fundamentals Check: Can Biofrontera Inc Equity Warrant navigate macro headwindsQuarterly Profit Report & Safe Entry Trade Reports - baoquankhu1.vn
Biofrontera completes key study for Ameluz skin treatment expansion By Investing.com - Investing.com South Africa
Biofrontera Emerges as Stronger Biotech Stock Compared to RenovaCare - National Today
Biofrontera completes key study for Ameluz skin treatment expansion - Investing.com
Biofrontera Inc (NASDAQ: BFRI) recently announced that the database lock for its Phase I pharmacokinetic study of Ameluz® for actinic keratosis on the trunk and extremities has been completed. - Bitget
Biofrontera Inc. Announces Database Lock of Phase 1 - GlobeNewswire
Travel Stocks: Does Biofrontera Inc have a sustainable dividend2025 Biggest Moves & High Return Trade Opportunity Guides - baoquankhu1.vn
Biofrontera reports positive phase 3 data for Ameluz in actinic keratosis - MSN
Bull Run: Is now the right time to enter Biofrontera Inc Equity Warrant - baoquankhu1.vn
BFRI SEC FilingsBiofrontera Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Fundamentals Check: Why ETFs are accumulating Biofrontera AG (B8FK) stockJuly 2025 PostEarnings & Stepwise Trade Execution Plans - mfd.ru
Signal Recap: Is Biofrontera Inc stock a hidden gemTrade Volume Summary & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Is Biofrontera Inc. stock near bottom after declineMarket Trend Review & AI Forecast Swing Trade Picks - mfd.ru
Biofrontera Inc. (NASDAQ:BFRI) Sees Significant Decline in Short Interest - Defense World
Will Biofrontera Inc. Equity Warrant benefit from AI trendsDollar Strength & Scalable Portfolio Growth Methods - mfd.ru
Biofrontera announces FDA filing acceptance of supplemental new drug application for Ameluz® PDT in superficial Basal Cell Carcinoma - marketscreener.com
Biofrontera Announces FDA Filing Acceptance of Supplemental - GlobeNewswire
Biofrontera's light-based option for common skin cancer under FDA review - Stock Titan
Biofrontera’s Ameluz shows strong results in actinic keratosis trial By Investing.com - Investing.com Australia
Biofrontera announces positive results in phase 3 study of Ameluz® PDT - marketscreener.com
Biofrontera Reports Positive Phase 3 Ameluz PDT Results - TipRanks
Biofrontera’s Ameluz shows strong results in actinic keratosis trial - Investing.com
Light therapy gel clears more actinic keratoses on limbs, neck - Stock Titan
Biofrontera (NASDAQ:BFRI) Trading Down 5.6% – Here’s What Happened - Defense World
Biofrontera Inc. (BFRI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Finviz
Is Biofrontera Inc. (BFRI) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
0.66%
1.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):